1

Advanced NSCLC: Navigating the Revolution...NAVIGATING THE REVOLUTION MONDAY, OCTOBER 10, 2016 | VENUE: BELLA CENTER, COPENHAGEN, DENMARK ROOM: BRUSSELS AUDITORIUM Top experts lead

Download PDF Report

Upload
others
View
4
Download
0

Embed Size (px)

Citation preview

Advanced NSCLC: Navigating the Revolution

The Evolving Treatment Landscape in NSCLC

The Evolving Treatment Landscape in NSCLC

Documents

LungNet: Shallow CNN models for NSCLC

LungNet: Shallow CNN models for NSCLC

Documents

Targeting oncogenic drivers in NSCLC - OncologyPROoncologypro.esmo.org/content/download/98588/1730732/file/ESMO... · Targeting oncogenic drivers in NSCLC ... ETOP sponsored,

Targeting oncogenic drivers in NSCLC - OncologyPROoncologypro.esmo.org/content/download/98588/1730732/file/ESMO... · Targeting oncogenic drivers in NSCLC ... ETOP sponsored,

Documents

NSCLC - InOncology · 2020-06-15 · NSCLC, the most common type of lung cancer, is genomically diverse ALK, anaplastic lymphoma kinase; EGFR, epidermal growth factor receptor; NSCLC,

NSCLC - InOncology · 2020-06-15 · NSCLC, the most common type of lung cancer, is genomically diverse ALK, anaplastic lymphoma kinase; EGFR, epidermal growth factor receptor; NSCLC,

Documents

Drugs to treat nsclc

Drugs to treat nsclc

Healthcare

NSCLC Forum: Bringing the Patient to the Foreground of Evidence-Based Lung Cancer Care Latest Data and Practical Guidance for Navigating a Complex Treatment Landscape

NSCLC Forum: Bringing the Patient to the Foreground of Evidence-Based Lung Cancer Care Latest Data and Practical Guidance for Navigating a Complex Treatment Landscape

Health & Medicine

nonsquamous NSCLC

nonsquamous NSCLC

Health & Medicine

Second line therapy for nsclc

Second line therapy for nsclc

Health & Medicine

Early Stage Nsclc The Role Of Chemotherapy

Early Stage Nsclc The Role Of Chemotherapy

Health & Medicine

Emerging Targets for Squamous Cell NSCLC

Emerging Targets for Squamous Cell NSCLC

Documents

Immune checkpoint inhibitors in NSCLC - OncologyPRO€¦ · Dxnot approved fordurvalumabin any setting Dxnot approved foravellumabin US/EU: any setting NSQ NSCLC EU: NSQ NSCLC Approved

Immune checkpoint inhibitors in NSCLC - OncologyPRO€¦ · Dxnot approved fordurvalumabin any setting Dxnot approved foravellumabin US/EU: any setting NSQ NSCLC EU: NSQ NSCLC Approved

Documents

Improving Outcomes in Advanced NSCLC with Immune ...•5-year survival rate is 19% (NSCLC + SCLC) •From 2009–2015, the relative survival rate for NSCLC was 25% •Recent overall

Improving Outcomes in Advanced NSCLC with Immune ...•5-year survival rate is 19% (NSCLC + SCLC) •From 2009–2015, the relative survival rate for NSCLC was 25% •Recent overall

Documents

Navigating the fourth industrial revolution to the bottom line€¦ · 6 Navigating the Fourth Industrial Revolution to the bottom line What 4IR technology is being deployed… and

Navigating the fourth industrial revolution to the bottom line€¦ · 6 Navigating the Fourth Industrial Revolution to the bottom line What 4IR technology is being deployed… and

Documents

CCO Metastatic NSCLC Slides

CCO Metastatic NSCLC Slides

Documents

Emerging Treatment Paradigms in NSCLC

Emerging Treatment Paradigms in NSCLC

Documents

Nsclc slide deck

Nsclc slide deck

Health & Medicine

Indications for sublobar resection for localized NSCLC

Indications for sublobar resection for localized NSCLC

Documents

NSCLC - Stage IV STAGE IVNSCLC. NSCLC - Stage IV NSCLC Main Drugs Stage IV NAVELBINE:The pivotal drug GEMZAR:Main competitor TAXOL:Still often prescribed

NSCLC - Stage IV STAGE IVNSCLC. NSCLC - Stage IV NSCLC Main Drugs Stage IV NAVELBINE:The pivotal drug GEMZAR:Main competitor TAXOL:Still often prescribed

Documents

Navigating the fourth industrial revolution to the …/media/B8C99947A3AF4A...4 Navigating the Fourth Industrial Revolution to the bottom line The Takeaway While the sector as a whole

Navigating the fourth industrial revolution to the …/media/B8C99947A3AF4A...4 Navigating the Fourth Industrial Revolution to the bottom line The Takeaway While the sector as a whole

Documents

Locally Advanced Nsclc

Locally Advanced Nsclc

Health & Medicine

Treatment of ALK Positive Advanced NSCLC · Treatment of ALK Positive Advanced NSCLC ... • First identified in NSCLC cells in 2007 ... Chemistry of ALK Tyrosine Kinase Inhibitors

Treatment of ALK Positive Advanced NSCLC · Treatment of ALK Positive Advanced NSCLC ... • First identified in NSCLC cells in 2007 ... Chemistry of ALK Tyrosine Kinase Inhibitors

Documents

Health & Medicine

Surgical Approach to NSCLC

Surgical Approach to NSCLC

Documents

Brain Metastases in NSCLC Boone Goodgame, MD

Brain Metastases in NSCLC Boone Goodgame, MD

Documents

Concurrent ChemoRT in NSCLC

Concurrent ChemoRT in NSCLC

Documents

Navigating The Revolution - Key Trends And How Clubs Can Use Technology IHRSA 2015

Navigating The Revolution - Key Trends And How Clubs Can Use Technology IHRSA 2015

Health & Medicine

Health & Medicine

Biomarker testing in non- small cell lung cancer (NSCLC) · NSCLC is both histologically and genetically diverse. 3. Prevalence of genetic alterations in NSCLC. 4. 40%. 25%. 10%

Biomarker testing in non- small cell lung cancer (NSCLC) · NSCLC is both histologically and genetically diverse. 3. Prevalence of genetic alterations in NSCLC. 4. 40%. 25%. 10%

Documents

NSCLC: Targeted Therapies and Beyond · approved for the treatment of NSCLC. There are also drugs that target specific NSCLC–associated mutations. For example, 10-35 percent of

NSCLC: Targeted Therapies and Beyond · approved for the treatment of NSCLC. There are also drugs that target specific NSCLC–associated mutations. For example, 10-35 percent of

Documents

Treatment strategies for oncogenic addicted NSCLC patients

Treatment strategies for oncogenic addicted NSCLC patients

Documents